AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
219.26
+1.15 (0.53%)
At close: Jan 23, 2026, 4:00 PM EST
219.28
+0.02 (0.01%)
After-hours: Jan 23, 2026, 7:59 PM EST
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,084,436
Profits / Employee
$42,691
Market Cap
387.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | 0 | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| AstraZeneca | 92,900 |
| Sanofi | 82,878 |
| Pfizer | 81,000 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| Eli Lilly and Company | 47,000 |
ABBV News
- 8 days ago - AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) - PRNewsWire
- 8 days ago - Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study - Reuters
- 10 days ago - AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - AbbVie plans to build out its presence in obesity market - Reuters
- 11 days ago - AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs. - Barrons
- 12 days ago - AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices - WSJ
- 12 days ago - Abbvie, US reach agreement to cut drug prices - Reuters
- 12 days ago - AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans - PRNewsWire